USPTO serial 90356449
PUMAS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 21, 2021
- Examiner
- RENNEKER, CHRISTOPHER JOHN
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with PUMAS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Centreville, VA, US
Centreville, VA, US
Baltimore, MD, US
DOVER, DE, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Devon E. White
Devon E. White WYRICK ROBBINS YATES & PONTON LLP4101 LAKE BOONE TRAIL, SUITE 300RALEIGH, NC 27607United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | downloadable computer software that uses artificial intelligence for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; downloadable computer software that uses artificial intelligence for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; software featuring machine learning and artificial intelligence for data analysis in the fields of data processing, analytics, information processing, data analysis, artificial intelligence, machine learning, deep learning, compound property prediction, compound structure prediction and data visualization in the fields of chemistry, pharmaceutical and agrochemical research and development; downloadable computer software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis for guiding experiment and study related decisions, namely, dose selection, patient selection, risk factor identification, endpoint selection, and for identifying genomic markers for efficacy and safety in support of regulatory submission to support product registration; downloadable computer artificial intelligence software for use in the pharmaceutical industry for drug discovery and design, clinical trial design, and data analysis; downloadable computer software for use in biological and chemical research, development, validation and testing in the life sciences field, including primarily the fields of biology, genomics, proteomics and pharmaceuticals for characterizing mechanism of action, understanding systems level biology and pharmacology, guide dose selection, and identify predictors for efficacy and safety; downloadable software platform using machine learning and artificial intelligence for training deep learning models on medical data and for use in medical predictions for use by healthcare organizations, life science and pharmaceutical companies to enhance precision in care quality, improve patient experience and advance new drugs and treatment methods, namely, building translational models, identifying patterns unknown to biology, augmenting systems biology models, enabling quality-by-design for pharmaceutical manufacturing, guiding treatment trajectory, precision dosing, individualized therapy, and extraction of signal from imaging data; downloadable bioinformatics software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable software for use in healthcare information management and analysis, namely, for capturing, storing, aggregating, viewing, and analyzing medical data, medical test results, diagnostic data, slides and specimens, in the fields of healthcare, medical research and clinical research; downloadable medical data monitoring, and applications that record, monitor, and analyze medical data, patient data, and provide patient diagnosis risk assessment for identifying trends related to patient treatment | ACTIVE | Jun 19, 2019 |
| 035 | providing business intelligence services in the fields of medical devices, pharmaceuticals and the life sciences | ACTIVE | Jun 19, 2019 |
| 042 | research and development in the field of artificial intelligence software for managing, accessing and sharing information and data in the fields of performance metrics, data visualizations, and predictive analytics in the healthcare and life sciences industries; scientific advisory services in the nature of computer modeling services, namely, computer simulation from computer programs for conducting mathematical and statistical modeling and simulation of drug effects for third party pharmaceuticals, diagnostic, and health care products; design and development of computer software for use in pharmaceutical research and development; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics; research and analysis services in the fields of biology, biotechnology, bioinformatics and in the pharmaceutical field; scientific research, namely, providing data analytics and data modelling to others in the fields of medical and pharmaceutical research and development; providing temporary use of web-based software featuring predictive analytics in the healthcare and life sciences industries; providing temporary use of web-based software for managing, accessing, analyzing, and sharing information and data in the healthcare and life sciences industries, namely, information and data in the fields of real world evidence | ACTIVE | Jun 19, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pumas-AI Inc.
- Other trademarks owned by Pumas-AI Inc.
- Other trademarks owned by Pumas-AI Inc.
- Other trademarks owned by PUMAS-AI INC.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named PUMAS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Apr 8, 2025 | NURC | NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED | — |
| Mar 15, 2025 | C.7C | NEW CERTIFICATE UNDER SECTION 7 - PROCESSED | — |
| Mar 10, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 16, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 10, 2024 | ES7R | TEAS SECTION 7 REQUEST RECEIVED | — |
| Sep 21, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 6, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 6, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 6, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 6, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 6, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 16, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 2, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 2, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 7, 2020 | NWAP | NEW APPLICATION ENTERED | — |